6-K 1 v205725_6k.htm Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of December 2010
 
Commission File Number: 001-34541
 
CHINA CORD BLOOD CORPORATION
(Translation of registrant’s name into English)
 
48th Floor, Bank of China Tower
1 Garden Road
Central
                   Hong Kong S.A.R.                   
(Address of Principal Executive Offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes o                                No x
 
If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_______________.

 
 
 
 
Other Events

On December 16, 2010, the China Cord Blood Corporation (the “Company”) issued a press release (the “Press Release”) announcing that the Company will hold its annual general meeting of record at the Company’s Hong Kong office at 48/F, Bank of China Tower, 1 Garden Road, Central, Hong Kong, at 9:00 p.m. on February 18, 2011 Hong Kong Time (February 18, 2011 8:00 a.m. U.S. Eastern Time).  The shareholder record date is January 12, 2011.  A copy of the Press Release is attached hereto as Exhibit 99.1.
 
Exhibits
 
Exhibit No.
Description
 
99.1 
Press Release, dated December 16, 2010

 
2
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
  CHINA CORD BLOOD CORPORATION  
       
 
By:
/s/ Albert Chen  
  Name: Albert Chen  
  Title: Chief Financial Officer  
       
Dated: December 16, 2010